Quantcast
Home > Quotes > AGLE

Aeglea BioTherapeutics, Inc. Common Stock (AGLE) Quote & Summary Data

AGLE 
$9.04
*  
0.10
1.09%
Get AGLE Alerts
*Delayed - data as of Jul. 17, 2018  -  Find a broker to begin trading AGLE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    AGLE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 5.15 / $ 10.10
Today's High / Low
$ 9.51 / $ 9.02
Share Volume
200,723
50 Day Avg. Daily Volume
281,855
Previous Close
$ 9.14
52 Week High / Low
$ 12 / $ 2.81
Market Cap
197,604,221
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
200,723
50 Day Avg. Daily Volume:
281,855

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.82

Trading Range

The current last sale of $9.04 is 221.71% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.51 $ 12
 Low: $ 9.02 $ 2.81

Company Description (as filed with the SEC)

We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. We believe our novel approach of utilizing human enzymes offers advantages over bacterial enzyme-based approaches including a more favorable safety profile that may provide a greater likelihood of clinical success. Our capabilities in enzyme engineering, preclinical disease modelling, and drug development in both rare genetic disease and cancer allow us to identify and advance innovative opportunities to address important unmet medical needs for the benefit of patients.  ... More ...  

Risk Grade

Where does AGLE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 9.13
Open Date:
Jul. 17, 2018
Close Price:
$ 9.04
Close Date:
Jul. 17, 2018

Consensus Recommendation

Analyst Info